
Keytruda: The drug that makes as much money as Zara and has sparked debate over patent lifespans
The recent publication of the 2024 results of the multinational Merck, which operates as Merck Sharp & Dohme (MSD) outside the United States, has revealed an unprecedented figure in the history of the pharmaceutical industry. Sales of the drug Keytruda …